Inventiva S.A.
Inventiva S.A. (IVA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IVA · as of Jun 8, 2026
Key Statistics
Explore Inventiva S.A. Data
iva stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 87.5%
The IVA analyst consensus is Buy, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $16.50, representing +309.43% upside from the current price of $4.03.
Competitors & Peers
iva competitorsIVA
AVTX
CRBU
ENTA
EPRX
GNFTStock Performance
Full HistoryAbout Inventiva S.A.
Inventiva S.A. a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses…
what is inventiva s.a. · iva stock overview · inventiva s.a. company profile · who is inventiva s.a. ceo · iva NASDAQ · inventiva s.a. headquarters · inventiva s.a. business segments
About Stock Overview & Key Data
Inventiva S.A. (IVA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 10, 2020. As of the latest trading session, IVA stock price is $4.03, with a market capitalization of $209.5M. The stock has returned +11.33% over the past 12 months and -13.33% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Inventiva S.A. stock is Buy, with an average 12-month price target of $16.50. In fiscal year 2025, Inventiva S.A. reported revenue of $4.5M and net income of -$340.2M. For detailed data — including Inventiva S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Inventiva S.A. (IVA) stock price is $4.03. The stock is traded on NASDAQ under the ticker symbol IVA. The 52-week range is $2.85 – $7.98.